Market Research Report by Aarkstore Medical Imaging Markets
Posted May 20 2011 11:46am
The purpose of this Company Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. As such, the global medical imaging industry is primed to experience significant growth through the next decade. This report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.
Table of Contents :
1. Overview 11 1.1 Statement of Report 11 1.2 Scope of this Report 11 1.3 Methodology 12 1.4 Executive Summary 13 1.4.1 Outlook for Medical Imaging 13 1.4.2 Outlook for Computed Tomography (CT) 13 1.4.3 Outlook for Magnetic Resonance Imaging (MRI) 13 1.4.4 Outlook for Positron Emission Tomography (PET) 14 1.4.5 Outlook for Single-Photon Emission Computed Tomography (SPECT) 14 1.4.6 Outlook for Hybrid Modalities 14 1.4.8 Outlook for Mammography 15 1.4.9 Outlook for Digital Radiography/Computed Radiography (DR/CR) 16 1.4.10 Outlook for Image-Guided Radiation Therapy (IGRT) 16 1.4.11 Outlook for Cardiac CT Imaging 16 1.4.12 Outlook for CT Angiography 17 1.4.13 Outlook for Nuclear Medicine in Cardiac Imaging 17 1.4.14 Outlook for MRI vs. SPECT in Cardiac Procedures 17 1.4.15 Outlook for Echocardiography in Cardiac Imaging 17 1.4.16 Outlook for Optical Coherence Tomography (OCT) 18 1.4.17 Outlook for Health IT 18 1.5 Market Drivers in Medical Imaging 18 1.5.1 Diagnostic Imaging Hardware 18 1.5.2 Miniaturization/Computing power 18 1.5.3 Fusion/Multimodality 18 1.5.4 Diagnostic Imaging Software 19 1.5.5 3D/4D Imaging 19 1.5.6 Computer-Aided Detection (CAD) 19 1.5.7 Workflow Automation 19 1.5.8 Enabling Technologies 19 1.5.9 Digitization 19 1.5.10 Client-Server Technology 20 1.5.11 Interoperability and Standardization 20 1.6 Challenges in Medical Imaging 20 1.6.1 Legal and Regulatory Constraints 20 220.127.116.11 U.S. Healthcare Reform 20 18.104.22.168 Reimbursement 20 22.214.171.124 Intellectual Property Protection for Imaging Software 21 126.96.36.199 OEM Relationships 21 188.8.131.52 Budgetary Concerns 21 184.108.40.206 Equity Funding Constraints 22 1.7.3 Breakeven Analysis for Magnetic Resonance Imaging (MRI) 24 1.7.4 Reimbursement and Patient's Access for Medical Imaging in the U.S. 24